Clinical trial

Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the…

NCT00187928 · University of Florida, Other · Completed

Key facts

NCT number NCT00187928
Title Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder
Official title A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Determine the Efficacy and Safety of Adjunctive Topiramate in the Treatment of Obsessive-Compulsive Disorder
Lead sponsor University of Florida, Other
Collaborators Ortho-McNeil Pharmaceutical Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Obsessive-Compulsive Disorder
Intervention type Drug
Interventions Topiramate
Enrollment 96
Start date Jan 1, 2003
Primary completion Mar 1, 2006
Completion Mar 1, 2006
First posted Sep 16, 2005
Last update posted Oct 5, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies